After receiving a terminal cancer diagnosis in March 2017, Steve Aldrich refused to accept the palliative standard of care course of treatment. Instead, he decided to pursue curative treatment independently. 

Steve began by having his whole healthy genome and whole cancer genome and microbiome sequenced.  Control over these (and related) fundamental raw data sets enabled Steve to identify and pursue cutting edge, personalized treatment options. 

In the process, he uncovered the dire need for a patient-controlled facility to store and enable useful collaboration around fundamental health data sets, and in response, Steve catalyzed the development of ennov1.